Clinical Pharmacokinetics of the Angiotensin Converting Enzyme Inhibitors A Review
- 1 January 1985
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 10 (5), 377-391
- https://doi.org/10.2165/00003088-198510050-00001
Abstract
The angiotensin converting enzyme inhibitors are an important therapeutic advance in the treatment of patients with hypertension and congestive heart failure. In addition, they are useful...Keywords
This publication has 36 references indexed in Scilit:
- Haemodynamic Responses to Specific Renin-Angiotensin Inhibitors in Hypertension and Congestive Heart Failure A ReviewDrugs, 1984
- Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.1983
- Evaluation of a long-acting converting enzyme inhibitor (Enalapril) for the treatment of chronic congestive heart failureJournal of the American College of Cardiology, 1983
- CaptoprilDrugs, 1983
- Enalapril maleate and a lysine analogue (MK‐521): disposition in man.British Journal of Clinical Pharmacology, 1982
- Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjectsThe American Journal of Cardiology, 1982
- Effect of Food on the Bioavailability of Captopril in Healthy SubjectsThe Journal of Clinical Pharmacology, 1982
- THE PHYSIOLOGICAL DISPOSITION AND METABOLISM OF ENALAPRIL MALEATE IN LABORATORY-ANIMALS1982
- Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.Hypertension, 1981
- Disposition of captopril in normal subjectsClinical Pharmacology & Therapeutics, 1980